Success Metrics

Clinical Success Rate
84.3%

Based on 587 completed trials

Completion Rate
84%(587/696)
Active Trials
259(21%)
Results Posted
41%(241 trials)
Terminated
109(9%)

Phase Distribution

Ph not_applicable
673
55%
Ph phase_1
41
3%
Ph phase_2
178
15%
Ph phase_3
122
10%
Ph phase_4
85
7%
Ph early_phase_1
7
1%

Phase Distribution

48

Early Stage

178

Mid Stage

207

Late Stage

Phase Distribution1106 total trials
Early Phase 1First-in-human
7(0.6%)
Phase 1Safety & dosage
41(3.7%)
Phase 2Efficacy & side effects
178(16.1%)
Phase 3Large-scale testing
122(11.0%)
Phase 4Post-market surveillance
85(7.7%)
N/ANon-phased studies
673(60.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.0%

587 of 762 finished

Non-Completion Rate

23.0%

175 ended early

Currently Active

259

trials recruiting

Total Trials

1,213

all time

Status Distribution
Active(334)
Completed(587)
Terminated(175)
Other(117)

Detailed Status

Completed587
Recruiting197
unknown116
Terminated109
Withdrawn66
Not yet recruiting64

Development Timeline

Analytics

Development Status

Total Trials
1213
Active
259
Success Rate
84.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (0.6%)
Phase 141 (3.7%)
Phase 2178 (16.1%)
Phase 3122 (11.0%)
Phase 485 (7.7%)
N/A673 (60.8%)

Trials by Status

terminated1099%
withdrawn665%
completed58748%
suspended10%
active_not_recruiting625%
recruiting19716%
unknown11610%
enrolling_by_invitation111%
not_yet_recruiting645%

Recent Activity

Clinical Trials (1,213)

Showing 20 of 1,213 trialsScroll for more
NCT03158818

Chronic Hepatitis B Virus Infection in Zambia

Completed
NCT06072482Phase 4

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting
NCT07643909Not Applicable

Health-Related Social Needs Food Boxes Delivery Program

Not Yet Recruiting
NCT07639632Not Applicable

Reduce Inefficiencies in Management of Spasticity

Not Yet Recruiting
NCT05451953Not Applicable

Providing Oxygen During Intubation in the NICU Trial

Completed
NCT05680818Phase 3

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Active Not Recruiting
NCT05365529Not Applicable

Time-Restricted Eating for Type II Diabetes: TRE-T2D

Active Not Recruiting
NCT06855277Phase 3

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Recruiting
NCT07638033

A Real-world HCM-cohort Trial

Not Yet Recruiting
NCT03294863Not Applicable

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

Terminated
NCT04844866Phase 2

Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

Recruiting
NCT05958017Not Applicable

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

Recruiting
NCT06641466Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Recruiting
NCT05561725Phase 4

Perioperative Steroid Dosing on the APR in AIS

Completed
NCT07126860Not Applicable

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients

Active Not Recruiting
NCT05388565Not Applicable

Domestic Violence Enhanced Perinatal Care Program in China

Recruiting
NCT06261398Not Applicable

Better Birth Outcomes Through Technology, Education, and Reporting

Recruiting
NCT06585410Phase 3

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Recruiting
NCT07005102Phase 2

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Recruiting
NCT05991284Phase 4

Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation

Completed

Drug Details

Intervention Type
OTHER
Total Trials
1,213